# K220493: Plaxpot Multi Plasma

- Pathway: 510(k) (Traditional)
- Applicant: Gcs Co. Limited
- Decided: Oct 27, 2023 after 612 days
- Product code: QVJ (Low Power Electrosurgical Devices For Skin Lesion Destruction)
- Device class: 2
- Regulation: 21 CFR 878.4400
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K933002 (1994). 16 ancestors in all.
No later device cites it as a predicate yet.
0 of 17 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K201738: SubNovii Advanced Plasma Technology, Cartessa Aesthetics (2020) Summary page 5.

## Indications for use
PLAXPOT™ MULTI PLASMA is intended for the removal and destruction of skin lesions and coagulation of tissue.

Source page: https://510kreport.com/device/K220493
Methodology: https://510kreport.com/methodology